A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes

Metformin is the most often prescribed drug for people with type 2 diabetes (T2D). More than 120 million patients with T2D use metformin worldwide. However, monotherapy fails to achieve glycemic control in a third of the treated patients. Genetics contribute to some of the inter-individual variation...

Descripción completa

Detalles Bibliográficos
Autores principales: Damanhouri, Zoheir A., Alkreathy, Huda M., Alharbi, Fawaz A., Abualhamail, Haneen, Ahmad, Muhammad S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812811/
https://www.ncbi.nlm.nih.gov/pubmed/36619226
http://dx.doi.org/10.7150/ijms.77206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812811/
https://www.ncbi.nlm.nih.gov/pubmed/36619226
http://dx.doi.org/10.7150/ijms.77206

Ejemplares similares